Evidence map›Paper›PMID 35456883›Full record

ArticleMicroorganisms2022

Multilayer Regulation of

Sara Borghi, Ana Antunes, Andreas F Haag, Marco Spinsanti, Tarcisio Brignoli, Enea Ndoni, Vincenzo Scarlato, Isabel Delany

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Sara BorghiImmune Monitoring Laboratory, NYU Langone Health, 550 First Avenue, New York, NY 10016, USA.
Ana AntunesMabDesign, 69007 Lyon, France.
Andreas F HaagSchool of Medicine, University of St Andrews, North-Haugh, St Andrews KY16 9TF, UK.ORCID 0000-0002-6783-0231
Marco SpinsantiGlaxoSmithKline (GSK) Vaccines, 53100 Siena, Italy.ORCID 0000-0002-5098-3901
Tarcisio BrignoliSchool of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TH, UK.
Enea NdoniLonza Group AG, 4057 Basel, Switzerland.
Vincenzo ScarlatoDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-4227-677X
Isabel DelanyGlaxoSmithKline (GSK) Vaccines, 53100 Siena, Italy.
GlaxoSmithKline (Italy) · ITNYU Langone Health · USUniversity of Bologna · ITUniversity of Bristol · GBUniversity of St Andrews · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neisseria meningitidis colonizes the nasopharynx of humans, and pathogenic strains can disseminate into the bloodstream, causing septicemia and meningitis. NHBA is a surface-exposed lipoprotein expressed by all N. meningitidis strains in different isoforms. Diverse roles have been reported for NHBA in heparin-mediated serum resistance, biofilm formation, and adherence to host tissues. We determined that temperature controls the expression of NHBA in all strains tested, with increased levels at 30−32 °C compared to 37 °C. Higher NHBA expression at lower temperatures was measurable both at mRNA and protein levels, resulting in higher surface exposure. Detailed molecular analysis indicated that multiple molecular mechanisms are responsible for the thermoregulated NHBA expression. The comparison of mRNA steady-state levels and half-lives at 30 °C and 37 °C demonstrated an increased mRNA stability/translatability at lower temperatures. Protein stability was also impacted, resulting in higher NHBA stability at lower temperatures. Ultimately, increased NHBA expression resulted in higher susceptibility to complement-mediated killing. We propose that NHBA regulation in response to temperature downshift might be physiologically relevant during transmission and the initial step(s) of interaction within the host nasopharynx. Together these data describe the importance of NHBA both as a virulence factor and as a vaccine antigen during neisserial colonization and invasion.

Indexed as

4CmenBNeisseria meningitidisNHBAthermoregulationvaccine

Identifiers

PMID35456883
PMCPMC9031163
OpenAlexW4224287252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.